Danavish Pregabalin+Methylcobalamin 75mg/750mcg Capsule
By Danavish
Rx
10 Capsule in a Strip

Composition
Methylcobalamin(750mcg) + Pregabalin(75mg)

Manufacturer - Danavish Healthcare
Vetturnimadam Nagercoil ,Tamil Nadu

Expires on or after
August, 2025

liver
Danavish Pregabalin+Methylcobalamin 75mg/750mcg Capsule is considered safe for individuals with liver disease. Based on the limited available data, it appears that adjusting the dose of Danavish Pregabalin+Methylcobalamin 75mg/750mcg Capsule may not be necessary for these patients. However, if you have liver impairment, it is recommended to consult your doctor before using this medication. Dose adjustment may be required for individuals with liver issues, so it is important to seek advice from your physician if you have concerns about your liver health.

kidney
When taking Danavish Pregabalin+Methylcobalamin 75mg/750mcg Capsule, caution is advised for patients with kidney disease. Dose adjustment may be necessary, so consulting your doctor is important, especially if you have kidney impairment or concerns about it.

alcohol
Avoid drinking alcohol while taking Danavish Pregabalin+Methylcobalamin 75mg/750mcg Capsule as it may increase drowsiness.

driving
Take caution when driving while using Danavish Pregabalin+Methylcobalamin 75mg/750mcg Capsule, as it may decrease alertness, affect vision, and cause drowsiness or dizziness. Avoid driving if experiencing these symptoms. Danavish Pregabalin+Methylcobalamin 75mg/750mcg Capsule does not impact driving ability.

pregnancy
Danavish Pregabalin+Methylcobalamin 75mg/750mcg Capsule may be unsafe during pregnancy. Limited human studies and animal studies show potential harm to the baby. Consult your doctor for risks and benefits before use. If pregnant or planning, consult your physician before taking Danavish Pregabalin+Methylcobalamin 75mg/750mcg Capsule

breastfeeding
Caution should be exercised while breastfeeding and considering the use of Danavish Pregabalin+Methylcobalamin 75mg/750mcg Capsule. Limited data indicates potential transfer of the drug to breastmilk which could pose risks to the baby. Consult a doctor before use.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | NEURO CNS |
Action Class | - |
₹49
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 18-Nov-2024